|
09-14-2010, 09:25 PM
|
|||
|
|||
Panel Recommends Thigh Fracture Warning for Bone Drugs
The American Society of Bone and Mineral Research Femoral Fracture Task Force is recommending that US health regulators rewrite the warning labels for a popular class of osteoporosis drugs called bisphosphonates because of their possible association with atypical femur fractures. Bisphosphonates include drugs sold under the brand names Actonel, Boniva, and Fosamax. The task force [...]
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bone-Loss Drugs Linked to Higher Risk of Uncommon Thigh Break, Report Says | cancerfr | Bone Cancer | 0 | 09-14-2010 09:25 PM |
| NCI panel recommends Celsion's Phase III ThermoDox HEAT Study as Priority Clinical Tr | cancerfr | Adrenocortical Carcinoma | 0 | 08-04-2010 05:23 PM |
| NICE Recommends Two New Cancer Drugs This Month | cancerfr | Oral Cancer | 0 | 07-28-2010 03:16 PM |
| Wendy Gordon: Cancer Panel Warning: Babies Born Pre-Polluted | cancerfr | Liver Cancer | 0 | 05-10-2010 03:23 AM |
| DMPA injectible contraceptive associated with increased risk of bone fracture | cancerfr | Bone Cancer | 0 | 05-07-2010 02:41 PM |
Linear Mode
